Literature DB >> 28492452

The Changing Landscape of HIV Prevention in the United States: Health Department Experiences and Local Adaptations in Response to the National HIV/AIDS Strategy and High-Impact Prevention Approach.

Holly H Fisher1, Aba Essuon, Tamika Hoyte, Ekaterine Shapatava, Gene Shelley, Aisha Rios, Stephanie Beane, Stacey Bourgeois, Erica Dunbar, Tobey Sapiano.   

Abstract

OBJECTIVE: HIV prevention has changed substantially in recent years due to changes in national priorities, biomedical advances, and health care reform. Starting in 2010, motivated by the National HIV/AIDS Strategy (NHAS) and the Centers for Disease Control and Prevention's (CDC's) High-Impact Prevention (HIP), health departments realigned resources so that cost-effective, evidence-based interventions were targeted to groups at risk in areas most affected by HIV. This analysis describes how health departments in diverse settings were affected by NHAS and HIP.
METHODS: We conducted interviews and a consultation with health departments from 16 jurisdictions and interviewed CDC project officers who monitored programs in 5 of the jurisdictions. Participants were asked to describe changes since NHAS and HIP and how they adapted. We used inductive qualitative analysis to identify themes of change.
RESULTS: Health departments improved their HIV prevention practices in different ways. They aligned jurisdictional plans with NHAS and HIP goals, increased local data use to monitor program performance, streamlined services, and strengthened partnerships to increase service delivery to persons at highest risk for infection/transmission. They shifted efforts to focus more on the needs of people with diagnosed HIV infection, increased HIV testing and routine HIV screening in clinical settings, raised provider and community awareness about preexposure prophylaxis, and used nontraditional strategies to successfully engage out-of-care people with diagnosed HIV infection. However, staff-, provider-, and data-related barriers that could slow scale-up of priority programs were consistently reported by participants, potentially impeding the ability to meet national goals.
CONCLUSION: Findings suggest progress toward NHAS and HIP goals has been made in some jurisdictions but highlight the need to monitor prevention programs in different contexts to identify areas for improvement and increase the likelihood of national success. Health departments and federal funders alike can benefit from the routine sharing of successes and challenges associated with local policy implementation, considering effects on the overall portfolio of programs.

Entities:  

Mesh:

Year:  2018        PMID: 28492452     DOI: 10.1097/PHH.0000000000000575

Source DB:  PubMed          Journal:  J Public Health Manag Pract        ISSN: 1078-4659


  4 in total

1.  "Do I want PrEP or do I want a roof?": Social determinants of health and HIV prevention in the southern United States.

Authors:  Sayward E Harrison; Mariajosé Paton; Kathryn E Muessig; Alyssa C Vecchio; Lyd A Hanson; Lisa B Hightow-Weidman
Journal:  AIDS Care       Date:  2022-02-02

2.  HIV Prioritization and Risk Perception Among an Online Sample of Men Who Have Sex With Men in the United States.

Authors:  Erin M Kahle; Akshay Sharma; Stephen P Sullivan; Rob Stephenson
Journal:  Am J Mens Health       Date:  2018-05-21

3.  Strategies for increasing impact, engagement, and accessibility in HIV prevention programs: suggestions from women in urban high HIV burden counties in the Eastern United States (HPTN 064).

Authors:  Jasmine A Abrams; Michelle Odlum; Emily Tillett; Danielle Haley; Jessica Justman; Sally Hodder; Linda Vo; Ann O'Leary; Paula M Frew
Journal:  BMC Public Health       Date:  2020-09-03       Impact factor: 3.295

4.  Practical and Ethical Concerns in Implementing Enhanced Surveillance Methods to Improve Continuity of HIV Care: Qualitative Expert Stakeholder Study.

Authors:  Mara Buchbinder; Colleen Blue; Stuart Rennie; Eric Juengst; Lauren Brinkley-Rubinstein; David L Rosen
Journal:  JMIR Public Health Surveill       Date:  2020-09-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.